Overview

Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-off

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The study evaluated the efficacy of levodopa/carbidopa/entacapone vs levodopa/carbidopa in patients with Parkinson's disease and early wearing-off with levodopa
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Carbidopa
Entacapone
Levodopa